| Product Code: ETC7626029 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 Ireland Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for personalized medicine and advanced therapies |
4.2.2 Increasing investments in research and development in the cell and gene therapy sector |
4.2.3 Favorable government initiatives and policies supporting the biopharmaceutical industry in Ireland |
4.3 Market Restraints |
4.3.1 High costs associated with cell and gene therapy manufacturing services |
4.3.2 Regulatory challenges and compliance requirements in the sector |
4.3.3 Limited availability of skilled workforce with expertise in cell and gene therapy manufacturing |
5 Ireland Cell and Gene Therapy Manufacturing Services Market Trends |
6 Ireland Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 Ireland Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Ireland Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 Ireland Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 Ireland Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 Ireland Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 Ireland Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 Ireland Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 Ireland Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Manufacturing capacity utilization rate |
8.2 Number of successful clinical trials conducted in Ireland for cell and gene therapies |
8.3 Number of partnerships and collaborations established with biopharmaceutical companies for manufacturing services |
9 Ireland Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 Ireland Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ireland Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 Ireland Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 Ireland Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here